Influencia recíproca entre psicofármacos y función tiroidea
Dra. Paula
Dra. Paula Antúnez Referencias Bibliográficas 1. Hickie I, Bennett B, Mitchell P, Wilhelm K, Orlay W. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust N Z J Psychiatry 1996;30:246-52. 2. Dording CM. Antidepressant augmentation and combinations. Psychiatr Clin North Am. 2000;23:743-55. 3. Joffe RT. The use of thyroid supplements to augment antidepressant medication. Clin Psychiatry 1998;59 Suppl 5:26-9. 4. Afflelou S, Auriacombe M, Cazenave M, Chartres JP, Tignol J. Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases. Encephale 1997;23:209-17. 5. Prange AJ Jr. Novel uses of thyroid hormones in patients with affective disorders. Thyroid 1996;6:537-43. 6. Gyulai L, Bauer M, Bauer MS, Garcia-Espana F, Cnaan A, Whybrow PC.Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge. Biol Psychiatry 2003;53:899-905. 7. Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso- Mateos JL. Evaluation of thyroid function in lithium-naive bipolar patients. Eur Psychiatry 1999;14:341-5. 8. Benbassat CA, Molitch ME. The use of lithium in the treatment of hyperthyroidism. Endocrinologist 1998;8:383-7. 9. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone Thyroid 1998;8:909-13. 10. Deodhar S, Singh B, Pathak C, Sharan P, Kulhara P. Thyroid function in lithium-treated psychiatric patients: a cross-sectional study. Biol Trace Element Res 1999;67:151-163. 11. Ramschak-Schwarzer S, Stiegler RC, Dimai HP, Leb G. Interaction between psychotropic drugs and thyroid hormone metabolism-an overview. Acta Med Austriaca 2000;27:8-11. 12. Tellian FF, Rueda-Vasquez E. Effect of serum lithium levels on thyrotropin levels. South Med J 1993;86:1182-3. 13. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001;55:501-8. 14. Wison R, McKillop JH, Crochet GT, Pearson C, Jenkins C, Burns F, et al. The effect of lithium therapy on parameters thought to be envolved in the development of autoimmune thyroid disease. Clin Endocrinol 1991;34:357-61. 15. Scanelli G. Lithium thyrotoxicosis. Report of a case and review of the literature. Recenti Prog Med 2002;93:100-3. 16. Constantinou C, Bolaris S, Valcana T, Margarity M. Acute LiCl-treatment affects the cytoplasmic T4 availability and the expression pattern of thyroid hormone receptors in adult rat cerebral hemispheres. Neurosci Res 2005;51:235-41. 17. Pinna G, Broedel O, Eravci M, Stoltenburg- Didinger G, Plueckhan H, Fuxius S, et al. Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation. Biol Psychiatry 2003;54:1049-59. 18. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999;175:336-9. 19. Bocchetta A, Cherchi A, Loviselli A, Mossa P, Velluzzi F, Derai R, et al. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr Scand 1996; 94:45-8. 20. Dang AH, Hershman JM. Lithium-associated thyroiditis. Endocr Pract 2002; 8:232-6. 21. Ahmadi-Abhari SA, Ghaeli P, Fahimi F, Esfahanian F, Farsam H, Dehpour AR, et al. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry 2003;3:4-9. 22. Lombardi G, Panza N, Biondi B, Di Lorenzo L, Lupoli G, Muscettola G, et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study.J Endocrinol Invest 1993,16:259-63. 23. Gracious BL, Findling RL, Seman C, Youngstrom EA, Demeter CA, Calabrese JR. Elevated thyrotropin in bipolar youths prescribed both lithium and divalproex sodium. J Am Acad Child Adolesc Psychiatry 2004;43:215-20. 24. Shulman KI, Sykora K, Gill SS, Mamdani M, Anderson G, Marras C, et al. New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice. Am J Geriatr Psychiatry 2005;13:299-304. 25. Kleiner J, Altshuler L, Hendrick V, Hershman JM. Kleiner J, Altshuler L, Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 1999;60:249-55. 26. Verrotti A, Basciani F, Morresi S, Morgese G, Chiarelli F. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 2001; 25:43-6. 27. Isojarvi JI, Pakarinen AJ, Myllyla VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33:142-8. 28. Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachatre G. Relationship between psychotropic drugs and thyroid function: a review. Toxicol Appl Pharmacol 1998;149:127-35. 29. Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J, Myllyla VV. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001;42:930-4. 30. Vainionpaa LK, Mikkonen K, Rattya J, Knip M, Pakarinen AJ, Myllyla VV, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004;45:197-203. 31. Pack A. Effects of Treatment on Endocrine Function in Patients with Epilepsy. Curr Treat Options Neurol 2005;7:273-80. 32. Verma NP, Haidukewych D. Differential but infrequent alterations of hepatic enzyme levels and thyroid hormone levels by anticonvulsant drugs. Arch Neurol 1994;51:381-4. 33. Catalano MG, Fortunati N, Pugliese M, Costantino L, Poli R, Bosco O, et al. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab 2005;90:1383-9. 34. Caksen H, Dulger H, Cesur Y, Odabas D, Tuncer O, Atas B. No effect of long-term valproate therapy on thyroid and parathyroid functions in children. Int J Neurosci 2002;112:1371-4. 35. Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, Lojo-Rocamonde S, Novo-Rodriguez I, Castro- Gago M. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999;40:1761-6. 36. Baumgartner A, Pietzcker A, Gaebel W. The hypothalamic-pituitary-thyroid axis in patients with schizophrenia. Schizophr Res 2000;44:233-43. 37. Kelly DL, Conley RR. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 2005;66:80-4. 38. Sauvage MF, Rousseau A, Marquet P, Dumeirain F, Raby C, Lachatre G. In vitro and in vivo study of the antithyroid side effects of trimeprazine. Toxicol Appl Pharmacol 1999;158:125-31. 39. Eravci M, Pinna G, Meinhold H, Baumgartner A. Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 2000;141:1027-40. 40. Grunder G, Wetzel H, Schlosser R, Anghelescu I, Hillert A, Lange K, et al. Neuroendocrine response to antipsychotics: effects of drug type and gender. Biol Psychiatry 1999;45:89-97. 41. Takorabet L, Ropars A, Raby C, Charreire J. Phenothiazine induces de novo MHC class II antigen expression on thyroid epithelial cells. J Immunol 1995;154:3593-602. 42. Paunovic VR, Timtojevic I, Marinkovic D. Neuroleptic actions on the thyroid axis: Different effects of clozapine and haloperidol. Int Clin Psychopharmacol 1991;6:133-9. 43. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother 2000;34:483-6. 44. Chu H, Lin JC, Hsu YD. Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case. Acta Neurol Taiwan 2004;13:126-30. 45. Rao M, Ruhrmann S, Retey B, Liappis N, Fuger J, Kraemer M, et al. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry 1996;29:180-6. 46. Fountaoulakis K, Iacovides A, Grammaticos P, Kaprinis G, Bech P. Thyroid function in clinical subtypes of major depresión. BMC Psychiatry 2004;4:6-15. 47. Gitlin M, Altshuler LL, Frye MA, Suri R, Huynh EL, Fairbanks L, et al. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J Psychiatry Neurosci 2004;29:383-6. 48. Appelhof BC, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Huyser J, et al. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. J Clin Endocrinol Metab 2004;89:6271-6. 49. Lifschytz T, Gur E, Lerer B, Newman ME. Effects of triiodothyronine and fluoxetine on 5- HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 2004;140:133-9. 50. Mooradian AD, Li JP. Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue. Exp Brain Res 2000;132:276-8. 51. Konig F, Hauger B, von Hippel C, Wolfersdorf M, Kaschka WP. Effect of paroxetine on thyroid hormone levels in severely depressed patients. Neuropsychobiology 2000;42:135-8. 52. Gordon JT, Tomlinson EE, Greenberg J, Dratman MB. An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3- induced hyperthyroid rats: implications for tricyclic antidepressant therapy. Pharmacol Exp Ther 1994;270:111-7. 53. Atterwill, CK, Catto LC, Heal DJ, Holland CW, Dickens TA, Jones CA. The effects of desipramine (DMI) and electroconvulsive shock (ECS) on the function of the hypothalamo-pituitary-thyroid axis in the rat. Psychoneuroendocrinology 1989;14:339-46. 54. Joffe RT, Singer W. The effects of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry 1990;23:67-9. 55. Shelton RC, Winn S, Ekhatore N, Loosen P. The effects of antidepressants on the thyroid axis in depression. Biol Psychiatry 1993;33:120-6. 56. Anderson RA, Mitchell R. Effects of gammaaminobutyric acid receptor agonists on the secretion of growth hormone, luteinizing hormone, adrenocorticotrophic hormone and thyroid-stimulating hormone from the rat pituitary gland in vitro. Endocrinol 1986;108:1-8. 57. Dalezios Y, Matsokis N. Nuclear benzodiazepine binding: possible interaction with thyroid hormone receptors. Neurochem Res 1993;18:305-11. 58. Constantinou C, Bolaris S, Valcana T, Margarity M. Diazepam affects the nuclear thyroid hormone receptor density and their expression levels in adult rat brain. Neurosci Res 2005;52:269-75. 59. Kragie L, Doyle D. Benzodiazepines inhibit temperature-dependent L-[125I]triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines. Endocrinology 1992;130:1211-6. 60. Grandison L. Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology 1983;22:1505-10. 61. Miyawaki I, Moriyasu M, Funabashi H, Yasuba M, Matsuoka N. Mechanism of clobazam-induced thyroidal oncogenesis in male rats. Toxicol Lett 2003;145:291-301. 62. Ortiz-Butron R, Pacheco-Rosado J, Hernandez- Garcia A, Briones-Velasco M, Rocha L. Mild thyroid hormones deficiency modifies benzodiazepine and mu-opioid receptor binding in rats. Neuropharmacology 2003;44:111-6. 63. Martin JV, Williams DB, Fitzgerald RM, Im HK, Vonvoigtlander PF. Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain. Neuroscience 1996;73:705-13. 64.Gavish M, Weizman A, Okun F, Youdim MB. Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the rat. J Neurochem 1986;47:1106-10. 65. Go T, Ito M, Okuno T, Mikawa H. Effect of thyroid hormones on benzodiazepine receptors in neuron-enriched primary cultures. Neurochem 1988;51:1497-500. 66. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust N Z J Psychiatry 2001;35:833-40. 20 // EDITORIAL SCIENS
